Moderna (NASDAQ:MRNA) Beats Expectations in Q2 CY2026
Reports second quarter revenue of $0.1 billion, GAAP net loss of $(0.8) billion and GAAP EPS of $(1.97)
Barchart Research What to Expect from MRNA Earnings MRNA Generated July 30, 2026 Current Price $57.92 EPS Estimate $$-1.97 Consensus Rating Hold Average Move 6.13% Moderna's Revenue Decline May Be Slowing,...
Moderna (MRNA) Q2 Earnings: What To Expect
1 Healthcare Stock to Keep an Eye On and 2 We Avoid
It is a mammoth week on the earnings front with a plethora of important companies reporting. This week could make or break the market. This week we have Apple, Microsoft, Amazon, Meta Platforms, Exxon...
Q1 Earnings Highlights: Moderna (NASDAQ:MRNA) Vs The Rest Of The Therapeutics Stocks
Therapeutics Stocks Q1 Highlights: Moderna (NASDAQ:MRNA)
Moderna is likely to announce its fiscal second-quarter earnings by the end of this month, and analysts expect its losses to narrow.